ACIU
ACIU
NASDAQ · Biotechnology

Ac Immune Sa

$2.92
-0.05 (-1.68%)
As of May 9, 1:55 AM ET ·
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Buy 9 90%
Hold 1 10%
Sell 0 0%
Price Target
Analyst Price Target +714.4% upside
Low Target $21.93
Average Target $23.78
High Target $37.21
Current Price $2.92
Current
$2.92
Target
$23.78
$21.93 $23.78 avg $37.21
Scenario Analysis
Bear Case
$21.93
651.0%
Low target
Base Case
$23.78
+714.4%
Avg target
Bull Case
$37.21
+1,174.3%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$4.00
-27.0% from high
52-Week Low
$1.51
+93.4% from low
Target vs 52W High
$23.78
+494.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 75% $257.58 +27.8%
AMGN
Amgen Inc
Hold 44 48% $190.87 -42.5%
GILD
Gilead Sciences Inc
Strong Buy 39 79% $362.68 +176.2%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 +2.0%
REGN
Regeneron Pharmaceuticals
Strong Buy 38 79% $76.80 -89.3%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 75% $102.31 -65.3%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -19.5%
INSM
Insmed Inc
Strong Buy 28 96% $143.40 +41.5%